VIRP logo

Virbac SA Stock Price

ENXTPA:VIRP Community·€3.0b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

VIRP Share Price Performance

€356.50
37.50 (11.76%)
€403.20
Fair Value
€356.50
37.50 (11.76%)
11.6% undervalued intrinsic discount
€403.20
Fair Value
Price €356.50
AnalystConsensusTarget €403.20

VIRP Community Narratives

AnalystConsensusTarget·
Fair Value €403.2 11.6% undervalued intrinsic discount

Future R&D And Facility Expansion Will Introduce New Products In Pet Care And Pharmaceuticals

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative

Trending Discussion

Updated Narratives

VIRP logo

VIRP: Accelerated Regional Momentum Will Sustain an Upgraded Bullish Outlook for 2025

Fair Value: €403.2 11.6% undervalued intrinsic discount
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet and fair value.

0 Risks
2 Rewards

Virbac SA Key Details

€1.4b

Revenue

€476.9m

Cost of Revenue

€955.9m

Gross Profit

€822.8m

Other Expenses

€133.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
15.88
66.72%
9.29%
27.2%
View Full Analysis

About VIRP

Founded
1968
Employees
6365
CEO
Paul Martingell
WebsiteView website
corporate.virbac.com

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.

Recent VIRP News & Updates

Recent updates

No updates